secwatch.observer — SEC 8-K summary
======================================

Issuer:     HOOKIPA Pharma Inc. (HOOK)
CIK:        0001760542
Form:       8-K
Filed at:   2024-06-18T23:59:59+00:00
Accession:  0001104659-24-072792
Event type: other
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HOOKIPA shareholders approve doubling authorized shares and authorize reverse split
--------------------------------------------------------------------------------

- Authorized common stock increased from 200M to 400M shares; approved by 64.8M for, 3.4M against.
- Shareholders authorized board to implement reverse stock split (1:2 to 1:10) before June 17, 2025; 63.4M for, 4.7M against.
- Directors Timothy Reilly and Malte Peters elected to Class II with 51.9M and 53.9M votes respectively.
- Ratification of PwC Wirtschaftsprüfung GmbH as independent auditor for FY2024 approved (67.6M for).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1760542/000110465924072792/0001104659-24-072792-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1760542/000110465924072792/tm2417487d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-072792

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer